Naoyoshi Nagata
Tokyo Medical University
177 Papers
280 Citations
Naoyoshi Nagata is an academic researcher from Tokyo Medical University. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 27, co-authored 135 publications. Previous affiliations of Naoyoshi Nagata include University of Tokyo & Kumamoto University.
Chat about Author
Papers
External validation of the NOBLADS score, a risk scoring system for severe acute lower gastrointestinal bleeding.
TL;DR: The moderately high generalizability of NOBLADS, a clinical risk score for severe LGIB, is confirmed and Appropriate triage using this score may support early decision-making in various hospitals.
Next endoscopic approach for acute lower gastrointestinal bleeding without an identified source on colonoscopy: upper or capsule endoscopy?
Tomonori Aoki,Naoyoshi Nagata,Atsuo Yamada,Takuro Shimbo,Yuuki Matsushita,Akira Shimomura,Sakurako Kobayashi,Shiori Moriyasu,Ryota Niikura,Toshiyuki Sakurai,Yoshihiro Hirata,Junichi Akiyama,Naomi Uemura,Kazuhiko Koike +13 more
TL;DR: When the definitive bleeding source is not identified by colonoscopy in patients with acute hematochezia, adjunctive endoscopy helps to identify the etiology and enables subsequent therapy, especially for patients without a colonic diverticulum.
Additional file 2: of A multicenter, randomized controlled trial comparing the identification rate of stigmata of recent hemorrhage and rebleeding rate between early and elective colonoscopy in outpatient-onset acute lower gastrointestinal bleeding: study protocol for a randomized controlled trial
Niikura Ryota,Naoyoshi Nagata,Yamada Atsuo,Doyama Hisashi,Shiratori Yasutoshi,Nishida Tsutomu,Yada Tomoyuki,Fujita Tomoki,Sumiyoshi Tetsuya,Kenkei Hasatani,Mikami, Tatsuya,Honda Tetsuro,Mabe Katsuhiro,Hara Kazuo,Yamamoto Katsumi,Takeda Mariko,Munenori Takata,Tanaka Mototsugu,Shinozaki Tomohiro,Fujishiro Mitsuhiro,Koike Kazuhiko +20 more
- 04 Apr 2018
Abstract: SPIRIT 2013 Checklist: Recommended items to address in a clinical trial protocol and related documents*. (DOC 121 kb)
Validation of British Society of Gastroenterology guidelines for acute lower gastrointestinal bleeding from 8,956 cases in Japan
Ken Kinjo,Tomonori Aoki,Atsushi Yamauchi,Atsuo Yamada,Jun Omori,Takashi Ikeya,Taiki Aoyama,Naoyuki Tominaga,Takaaki Kishino,Naoki Ishii,Tsunaki Sawada,Masaki Murata,Akinari Takao,Kazuhiro Mizukami,Shunji Fujimori,Takahiro Uotani,Minoru Fujita,Toshiaki Narasaka,Junnosuke Hayasaka,Tomohiro Funabiki,Yuzuru Kinjo,Akira Mizuki,Shu Kiyotoki,Tatsuya Mikami,Ryosuke Gushima,Hiroyuki Fujii,Yuta Fuyuno,Takuto Hikichi,Yosuke Toya,Kazuyuki Narimatsu,Noriaki Manabe,Koji Nagaike,Tetsu Kinjo,Yorinobu Sumida,Sadahiro Funakoshi,Tamotsu Matsuhashi,Yuga Komaki,Kazuhiro Watanabe,Takashi Hisabe,Kenshi Yao,Mitsuru Kaise,Naoyoshi Nagata +41 more
Effect of proton-pump inhibitors on the risk of lower gastrointestinal bleeding associated with NSAIDs, aspirin, clopidogrel, and warfarin
Naoyoshi Nagata,Ryota Niikura,Tomonori Aoki,Toshiyuki Sakurai,Shiori Moriyasu,Takuro Shimbo,Katsunori Sekine,Hidetaka Okubo,Kazuhiro Watanabe,Chizu Yokoi,Mikio Yanase,Junichi Akiyama,Naomi Uemura +12 more
TL;DR: It is demonstrated that PPI use did not lead to an increased risk of LGIB, regardless of the type of PPI used, and LGIB risk was not affected by PPI Use, irrespective of concomitant therapy with NSAIDs, low-dose aspirin, clopidogrel, or warfarin.